Industrial Bioprocessing Market Report 2026

Industrial Bioprocessing Market Overview

• Industrial Bioprocessing market size has reached to $18.95 billion in 2025 • Expected to grow to $29.05 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Demand For Biologics And Biopharmaceuticals Driving Growth In The Market Due To Increasing Prevalence Of Chronic Diseases • Market Trend: Strategic Partnerships Enhance Upstream Process Intensification And Biomanufacturing Efficiency In Industrial Bioprocessing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Industrial Bioprocessing Market?

Industrial bioprocessing is an industrial manufacturing process that uses biological systems such as microorganisms, enzymes, or living cells to carry out controlled biological reactions at a commercial scale. It involves the integration of biotechnology, process engineering, and monitoring systems to improve production efficiency, process consistency, and operational sustainability. The main types of industrial bioprocessing include upstream processing, downstream processing, process analytical technologies, and bioprocess consumables and accessories. Upstream processing refers to the initial stages of biomanufacturing that involve the cultivation, growth, and maintenance of microorganisms or cells used to produce biological products. These processes utilize technologies such as fermentation, biocatalysis, cell culture, and other technologies. The various applications involved are biopharmaceutical production, industrial enzymes, biofuels, food and beverage processing, wastewater treatment, and agricultural biotechnology, and they are used by several end users such as industrial, commercial, and residential end users.

What Is The Industrial Bioprocessing Market Growth Forecast?

The industrial bioprocessing market size is expected to see strong growth in the next few years. It will grow to $29.05 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for bio based chemicals and fuels, expansion of precision medicine and biologics production, increasing focus on cost efficient biomanufacturing processes, adoption of next generation cell culture technologies, growing demand for sustainable industrial production alternatives. Major trends in the forecast period include increasing adoption of single use bioprocessing systems for reduced contamination risk, rising demand for high efficiency downstream purification techniques, expansion of large scale fermentation capacity in industrial manufacturing, growing preference for modular and flexible bioreactor designs, increasing focus on regulatory compliant bio production workflows ensuring product consistency.

Global Industrial Bioprocessing Market Segmentation

1) By Type: Upstream Processing; Downstream Processing; Process Analytical Technologies; Bioprocess Consumables And Accessories 2) By Technology: Fermentation; Biocatalysis; Cell Culture; Other Technologies 3) By Application: Biopharmaceutical Production; Industrial Enzymes; Biofuels; Food And Beverage Processing; Wastewater Treatment; Agricultural Biotechnology 4) By End User: Industrial; Commercial; Residential Subsegments: 1) By Upstream Processing: Cell Culture Media; Buffer Solutions; Bioreactors; Fermentation Systems; Filtration Systems; Cell Separation Equipment; Sensors And Monitoring Devices 2) By Downstream Processing: Chromatography Systems; Filtration Technologies; Centrifugation Equipment; Drying Equipment; Purification Resins; Separation Membranes; Concentration Systems 3) By Process Analytical Technologies: Spectroscopy Systems; Chromatography Analyzers; Particle Size Analyzers; Biomass Monitoring Systems; Gas Analysis Systems; Ph Measurement Systems; Data Management Software 4) By Bioprocess Consumables And Accessories: Single Use Bags; Filters; Tubing Assemblies; Culture Media; Reagents; Sampling Devices; Connectors And Fittings

What Is The Driver Of The Industrial Bioprocessing Market?

The rising demand for biologics and biopharmaceuticals is expected to propel the growth of the industrial bioprocessing market going forward. Biologics and biopharmaceuticals are complex medicines produced using living cells or organisms to target and treat various medical conditions through biological mechanisms. Biologics and biopharmaceuticals are increasing due to the rising prevalence of chronic diseases, as these advanced therapies provide highly targeted and effective treatment options with improved clinical outcomes compared to conventional drugs. Industrial bioprocessing helps biologics and biopharmaceuticals by enabling the large-scale cultivation of cells and microorganisms used to produce complex biological drugs efficiently, consistently, and with high purity through controlled fermentation and downstream processing techniques. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the US had 33 biosimilar products approved by the FDA, with 21 available on the market. By 2023, FDA-approved biosimilars had increased to 40, with 25 commercially available. Therefore, the rising demand for biologics and biopharmaceuticals is driving the growth of the industrial bioprocessing industry.

Key Players In The Global Industrial Bioprocessing Market

Major companies operating in the industrial bioprocessing market are Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Sartorius Aktiengesellschaft; Avantor Inc.; Corning Inc.; GEA Group Aktiengesellschaft; Repligen Corporation; Entegris Inc.; Eppendorf SE; Parker Hannifin; Hamilton Company; ZETA Holding GmbH; Glatt Ingenieurtechnik GmbH; Rentschler Biopharma SE; Meissner Filtration Products Inc.; Shanghai Tofflon Science and Technology Co. Ltd.; ABEC Inc.; Codexis Inc.; PBS Biotech Inc.; Broadley-James Corporation; INFORS HT; CerCell ApS; Wacker Biotech GmbH; BPC Instruments AB; OmniBRx Biotechnologies Pvt. Ltd.; Bailun Biotechnology Co. Ltd.; Adolf Kühner AG; Fermenter Technologies Pty Ltd

Global Industrial Bioprocessing Market Trends and Insights

Major companies operating in the industrial bioprocessing market are focusing on developing strategic partnerships to enhance upstream processing efficiency, accelerate process intensification, and improve biomanufacturing productivity. Strategic partnerships refer to collaborative agreements between companies to combine technologies, expertise, and resources to accelerate innovation, improve operational efficiency, and expand capabilities in industrial bioprocessing. For instance, in August 2023, Sartorius AG, a Germany-based life sciences company, collaborated with Repligen Corporation, a US-based bioprocessing technology company, to launch an integrated system combining the Biostat STR bioreactor with XCell ATF technology for upstream process intensification. The solution is designed to enable high-density cell culture and intensified perfusion processes, improving productivity and efficiency in industrial bioprocessing applications used for the production of biologics such as monoclonal antibodies and other therapeutic proteins.

What Are Latest Mergers And Acquisitions In The Industrial Bioprocessing Market?

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio LLC for $600 million. Through this acquisition, Merck aimed to strengthen its viral vector bioprocessing capabilities, expand its cell and gene therapy manufacturing portfolio, and enhance end-to-end solutions for advanced biologics production. Mirus Bio LLC is a US-based biotechnology company that provides upstream bioprocessing for cell and gene therapy manufacturing.

Regional Outlook

North America was the largest region in the industrial bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Industrial Bioprocessing Market?

The industrial bioprocessing market consists of revenues earned by entities by providing services such as cell line development, bioprocess scale-up services, and technology transfer services. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial bioprocessing market also includes sales of bioreactors and fermenters, filtration systems, and single-use bioprocessing systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Industrial Bioprocessing Market Report 2026?

The industrial bioprocessing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the industrial bioprocessing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.